Global /India /Healthcare /Drug Manufacturers - General /540694

ANG Lifesciences India Ltd.

540694 (ANG)

• BSE: 540694 • Delayed

32.18INR -6.2%

0.3408 USD

As of 21 June 2026, ANG Lifesciences India Ltd. has a market cap of $4.45M USD, ranking #44937 globally and #3970 in India. It ranks #3984 in the Healthcare sector, and #1282 in the Drug Manufacturers - General industry.

Global Rank

44937

Country Rank

3970

Sector Rank

3984

Industry Rank

1282

Key Stats

Market Cap

$4.45MUSD

420.22M INR

Enterprise Value

$13.59MUSD

1.28B INR

Revenue (TTM)

$9.13MUSD

862.13M INR

EBITDA (TTM)

-$434.42KUSD

-41.02M INR

Net Income (TTM)

-$1.25MUSD

-117.64M INR

EBITDA Margin

-4.8%

Profit Margin

-14%

PS Ratio

0.5

PB Ratio

0.7

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Rajesh Gupta open_in_new

Employees

412

Founded

2006

Website

anglifesciences.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-6.2%	26%	78%	39%	5%	16%	28%	-59%	-28%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	540694 (ANG) ANG Lifesciences India Ltd ISIN: INE236W01016 Shares Out.: Shares Outstanding: 13.058M¹ Shares Float: 3.864M² TV: TradingView: BSE: ANG SA: Stock Analysis: BOM: 540694 YF: Yahoo Finance: 540694.BO GF: Google Finance: BOM: 540694 BA: Barron's: 540694 MS: Morningstar: XBOM: 540694	32.18 INR	TV: TradingView: BSE: ANG SA: Stock Analysis: BOM: 540694 YF: Yahoo Finance: 540694.BO GF: Google Finance: BOM: 540694 BA: Barron's: 540694 MS: Morningstar: XBOM: 540694

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About ANG Lifesciences India Ltd.

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 1M%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 413K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 341K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 263K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 222K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 218K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 17M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 12M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 8M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 7M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 6M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 6M%	15.1	United States

chevron_leftBack